A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs

por Little, Peter R, King, Vickie L, Davis, Kylie R, Cosgrove, Sallie B, Stegemann, Michael R
Publicado 2015

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(®)) in client‐owned dogs with atopic dermatitis

por Cosgrove, Sallie B., Wren, Jody A., Cleaver, Dawn M., Walsh, Kelly F., Follis, Stacey I., King, Vickie I., Tena, Jezaniah‐Kira S., Stegemann, Michael R.
Publicado 2013

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis

por Cosgrove, Sallie B, Wren, Jody A, Cleaver, Dawn M, Martin, David D, Walsh, Kelly F, Harfst, Jessica A, Follis, Stacey L, King, Vickie L, Boucher, Joseph F, Stegemann, Michael R
Publicado 2013